Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

S-Adenosyl-L-methionine (disulfate tosylate)

S-Adenosyl-L-methionine (Ademetionine) disulfate tosylate is the disulfate tosylate form of S-Adenosyl-L-methionine (HY-B0617) . S-Adenosyl-L-methionine disulfate tosylate is an orally active methyl group donor. S-Adenosyl-L-methionine disulfate tosylate is a dietary supplement with potent antidepressant effects. S-Adenosyl-L-methionine disulfate tosylate also has anti‑proliferative, pro‑apoptotic and anti‑metastatic roles in cancers. S-Adenosyl-L-methionine disulfate tosylate has the potential for, cancer, liver disease and osteoarthritis research[1][2][3].

Product Specifications

CAS Number

[97540-22-2]

Product Name Alternative

Ademetionine (disulfate tosylate) ; S-Adenosyl methionine (disulfate tosylate) ; AdoMet (disulfate tosylate)

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; Endogenous Metabolite

Type

Natural Products

Related Pathways

Apoptosis; Metabolic Enzyme/Protease

Applications

Neuroscience-Neuromodulation

Field of Research

Cancer; Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/S-Adenosyl-L-methionine_disulfate_tosylate.html

Concentration

10mM

Purity

99.50

Solubility

DMSO : ≥ 50 mg/mL|H2O : 250 mg/mL (ultrasonic)

Smiles

N[C@@H](CC[S+](C[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN=C3N)O1)O)O)C)C(O)=O.O=S(O)([O-])=O.O=S(O)(O)=O.OS(=O)(C4=CC=C(C)C=C4)=O

Molecular Formula

C22H34N6O16S4

Molecular Weight

766.80

Precautions

H302, H315, H319, H335

References & Citations

[1]Lu SC, et al. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev. 2012 Oct;92 (4) :1515-42.|[2]Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl. 1994;154:7-14.|[3]Najm WI, et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord. 2004 Feb 26;5:6.|[4]Mosca L, et al. Effects of S‑adenosyl‑L‑methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms. Int J Oncol. 2020 May;56 (5) :1212-1224. |[5]Ham MS, et al. S-adenosyl methionine specifically protects the anticancer effect of 5-FU via DNMTs expression in human A549 lung cancer cells. Mol Clin Oncol. 2013 Mar;1 (2) :373-378. |[6]Ornoy A, et al. S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice. Neurotoxicol Teratol. 2019 Jan-Feb;71:64-74.|[7]Dhediya RM, et al. Evaluation of antiepileptic effect of S-adenosyl methionine and its role in memory impairment in pentylenetetrazole-induced kindling model in rats. Epilepsy Behav. 2016 Aug;61:153-157.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, sealed storage, away from moisture)

Scientific Category

Natural Products

Clinical Information

Launched

Isoform

Human Endogenous Metabolite

Citation 01

Food Funct. 2025 Oct 27.|Pharmacol Res. 2024 Sep 16:107420.|Biochem Pharmacol. 2024 Jan:219:115967.|Biomed Pharmacother. 2025 Jun 20:189:118246.|bioRxiv. 2023 Jun 1.|Epigenetics Chromatin. 2021 Dec 4;14 (1) :52.|Gut Microbes. 2025 Dec;17 (1) :2545434.|Int Immunopharmacol. 2021 Jun:95:107545.|J Agric Food Chem. 2021 Aug 11;69 (31) :8737-8746.|J Exp Med. 2026 Jan 5;223 (1) :e20250603.|Mol Cancer. 2025 Nov 20;24 (1) :295.|Research Square Preprint. 2020 Aug.|Research Square Preprint. 2021 Jun.|bioRxiv. 2025 Jun 27.|Environ Sci Technol. 2025 Jan 14;59 (1) :268-278.|Nat Commun. 2024 Nov 12;15 (1) :9529.|Plant J. 2025 Apr;122 (2) :e70182.|J Cell Physiol. 2025 Jan;240 (1) :e31452.|Molecules. 2023 Apr 11;28 (8) :3375.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CD45 (B220, CD45R, GP180, Leukocyte common antigen (LCA), Loc, Ly-5, Lyt-4, Protein tyrosine phosphatase receptor type C (PTPRC), Receptor-type tyrosine-protein phosphatase C, T200 glycoprotein) (BSA & Azide Free) (MaxLight 650)
MBS6225744-01 0.1 mL

CD45 (B220, CD45R, GP180, Leukocyte common antigen (LCA), Loc, Ly-5, Lyt-4, Protein tyrosine phosphatase receptor type C (PTPRC), Receptor-type tyrosine-protein phosphatase C, T200 glycoprotein) (BSA & Azide Free) (MaxLight 650)

Ask
View Details
CD45 (B220, CD45R, GP180, Leukocyte common antigen (LCA), Loc, Ly-5, Lyt-4, Protein tyrosine phosphatase receptor type C (PTPRC), Receptor-type tyrosine-protein phosphatase C, T200 glycoprotein) (BSA & Azide Free) (MaxLight 650)
MBS6225744-02 5x 0.1 mL

CD45 (B220, CD45R, GP180, Leukocyte common antigen (LCA), Loc, Ly-5, Lyt-4, Protein tyrosine phosphatase receptor type C (PTPRC), Receptor-type tyrosine-protein phosphatase C, T200 glycoprotein) (BSA & Azide Free) (MaxLight 650)

Ask
View Details
Anti-RTN4R Antibody
CPA2768-01 30 µL

Anti-RTN4R Antibody

Ask
View Details
Anti-RTN4R Antibody
CPA2768-02 50 μL

Anti-RTN4R Antibody

Ask
View Details
Anti-RTN4R Antibody
CPA2768-03 100 µL

Anti-RTN4R Antibody

Ask
View Details
Anti-RTN4R Antibody
CPA2768-04 200 µL

Anti-RTN4R Antibody

Ask
View Details